Literature DB >> 22703940

Reduced flow-mediated vasodilation of brachial artery in children with primary snoring.

Albert M Li1, Chun T Au, P Chook, Hugh S Lam, Yun K Wing.   

Abstract

BACKGROUND: Sleep disordered breathing, especially obstructive sleep apnea, is associated with endothelial dysfunction in both adults and children. However, the role of primary snoring (PS) on endothelial function has not been investigated. This study aimed to examine flow-mediated vasodilation (FMD) in both normal weight and overweight children with PS.
METHODS: Children aged 6-18 years with habitual snoring were recruited from our sleep disorder clinic. Non-snoring controls were recruited from participants of a community growth survey. All subjects underwent polysomnography and FMD evaluation on the same day. Children with body mass index of greater than the 85th percentile of the local reference were defined as overweight. Subjects were divided into groups of normal weight, overweight, non-snorers and PS for comparisons.
RESULTS: Two hundred and one children, of whom 83 were overweight, with a mean ± SD age of 11.3 ± 2.7 years were recruited. Seventy three out of 201 children had PS. Both normal weight (7.9 ± 1.3 vs. 8.5 ± 0.9, p=0.012) and overweight subjects (7.4 ± 1.4 vs. 8.1 ± 1.1, p=0.006) with PS had significantly reduced FMD than the non-snoring controls. Multivariate linear regression model showed that PS was independently associated with reduced FMD in both normal weight (p=0.014) and overweight subgroups (p=0.016) after controlling for obstructive apnea hypopnea index.
CONCLUSIONS: PS in children is associated with reduced FMD, independent of obesity.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Children; Endothelial function; Flow-mediated vasodilation; Obesity; Primary snoring

Mesh:

Year:  2012        PMID: 22703940     DOI: 10.1016/j.ijcard.2012.05.108

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Childhood obesity-related endothelial dysfunction: an update on pathophysiological mechanisms and diagnostic advancements.

Authors:  Luc Bruyndonckx; Vicky Y Hoymans; Katrien Lemmens; José Ramet; Christiaan J Vrints
Journal:  Pediatr Res       Date:  2016-02-11       Impact factor: 3.756

2.  Effect of Sleep-disordered Breathing Severity on Cognitive Performance Measures in a Large Community Cohort of Young School-aged Children.

Authors:  Scott J Hunter; David Gozal; Dale L Smith; Mona F Philby; Jaeson Kaylegian; Leila Kheirandish-Gozal
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

3.  Cerebral Blood Flow Response to Hypercapnia in Children with Obstructive Sleep Apnea Syndrome.

Authors:  David R Busch; Jennifer M Lynch; Madeline E Winters; Ann L McCarthy; John J Newland; Tiffany Ko; Mary Anne Cornaglia; Jerilynn Radcliffe; Joseph M McDonough; John Samuel; Edward Matthews; Rui Xiao; Arjun G Yodh; Carole L Marcus; Daniel J Licht; Ignacio E Tapia
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

Review 4.  The cardiovascular risk in paediatrics: the paradigm of the obstructive sleep apnoea syndrome.

Authors:  Marco Zaffanello; Giorgio Piacentini; Stefania La Grutta
Journal:  Blood Transfus       Date:  2020-03-17       Impact factor: 3.443

5.  Plasma natriuretic peptides in children and adolescents with obstructive sleep apnea and their changes following intervention.

Authors:  Albert Martin Li; Chun Ting Au; Jodie Y Zhu; Kate Ching Ching Chan; Michael Ho Ming Chan; Dennis Lip Yen Lee; Yun Kwok Wing
Journal:  Front Pediatr       Date:  2014-03-24       Impact factor: 3.418

6.  Mean Platelet Volume, Vitamin D and C Reactive Protein Levels in Normal Weight Children with Primary Snoring and Obstructive Sleep Apnea Syndrome.

Authors:  Anna Maria Zicari; Francesca Occasi; Federica Di Mauro; Valeria Lollobrigida; Marco Di Fraia; Vincenzo Savastano; Lorenzo Loffredo; Francesco Nicita; Alberto Spalice; Marzia Duse
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.